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Abstract  We  report  the  case  of  a  52-year-old  man  who  presented  to  our  emergency  depart-
ment (ED)  after  three  episodes  of  syncope  in  the  seven  hours  before  admission.  During  his
stay in  the  ED  he  had  recurrent  ventricular  tachycardia  (VT)  requiring  external  electrical  car-
dioversion.  A  12-lead  electrocardiogram  (ECG)  showed  a  short  QT  (SQT)  interval  (270  ms,  QTc
327 ms),  with  frequent  R-on-T  extrasystoles  triggering  sustained  polymorphic  VT.  After  exclu-
sion of  other  precipitating  causes,  the  patient  was  diagnosed  as  having  SQT  syndrome  (SQTS)
according  to  the  Gollob  criteria.  To  our  knowledge,  this  is  the  ﬁrst  known  documentation  of  an
SQT-caused  arrhythmic  episode  on  a  12-lead  ECG,  as  well  as  the  ﬁrst  reported  case  of  SQTS  in
Portugal.  The  patient  received  an  implantable  cardioverter-deﬁbrillator  and  was  discharged.
At a  follow-up  assessment  14  months  later  he  was  symptom-free,  interrogation  of  the  device
showed no  arrhythmic  events,  and  the  ECG  showed  a  QT  interval  of  320  ms  (QTc  347  ms).
© 2013  Sociedade  Portuguesa  de  Cardiologia.  Published  by  Elsevier  España,  S.L.U.  All  rights
reserved.
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Quando  o  intervalo  QT  é  curto  demais:  síncope  causada  por  síndrome  QT  Curto
Resumo  Os  autores  apresentam  o  caso  de  um  homem  com  52  anos  que  recorreu  ao  Servic¸o
de Urgência  (SU)  por  três  episódios  sincopais  ocorridos  nas  últimas  sete  horas  pré-admissão
loaded from http://www.elsevier.pt, day 30/12/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.cardíaca;
Arritmia  ventricular
hospitalar.  Durante  a  estadia  no  SU,  objetivaram-se  períodos  de  taquicardia  ventricular  (TV)
recorrente,  com  necessidade  de  cardioversão  elétrica  externa,  tendo  o  doente  sido  transferido
para a  unidade  de  cuidados  intensivos  cardíacos  para  monitorizac¸ão  e  orientac¸ão  clínica.  O  el-
ectrocardiograma  de  12  derivac¸ões  (ECG)  registado  no  contexto  de  um  dos  episódios  revelava
um intervalo  QT  curto  (260  ms,  QTc  327  ms)  em  ritmo  sinusal,  com  fenómeno  de  R-on-T
desencadeando  TV  polimórﬁca  mantida.  Após  exclusão  de  causas  precipitantes,  o  doente  foi
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classiﬁcado  como  tendo  Síndrome  QT  Curto  (SQTC),  de  acordo  com  os  critérios  de  Gollob.
Tanto quanto  é  do  nosso  conhecimento,  esta  é  a  primeira  documentac¸ão  no  ECG  de  um  episó-
dio arrítmico  causado  por  SQTC  e  a  primeira  descric¸ão  de  um  caso  de  SQTC  em  Portugal.  Foi
submetido  a  implantac¸ão  de  cardioversor-desﬁbrilhador  implantável  (CDI)  monocameral  e  teve
alta hospitalar.  No  seguimento  aos  14  meses  pós-implantac¸ão,  o  doente  negava  recorrência
da sintomatologia,  a  interrogac¸ão  do  CDI  não  mostrou  novos  episódios  arrítmicos,  e  no  ECG
persistia um  intervalo  QT  de  320  ms  (QTc  347  ms).
© 2013  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  España,  S.L.U.  Todos  os
direitos reservados.
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ECG  electrocardiogram
ED  emergency  department
ICD  implantable  cardioverter-deﬁbrillator
PVC  premature  ventricular  contractions
PVT  polymorphic  ventricular  tachycardia
QTc  corrected  QT
SQT  short  QT
SQTS  short  QT  syndrome
VT  ventricular  tachycardia
ase report
 52-year-old  man  presented  to  our  emergency  department
ED)  due  to  three  episodes  of  sudden  transient  loss  of  con-
ciousness  in  the  seven  hours  before  hospital  admission.  The
rst  event  occurred  at  2:00  am,  while  the  patient  was  lying
n  bed,  recurring  at  4:00  am  and  7:00  am.  He  reported
alaise,  but  denied  prodromes,  chest  pain,  palpitations  or
yspnea.  His  wife,  who  witnessed  the  episodes,  described
hem  as  lasting  for  about  ﬁve  minutes,  with  spontaneous  and
omplete  recovery.  There  was  no  evidence  of  seizure-like
ctivity.
The  patient  had  no  history  of  known  cardiovascular  dis-
ase  and  no  recollection  of  previous  episodes  of  syncope.
is  father  died  at  38  years  of  age  due  to  sudden  death  of
ndetermined  origin,  with  no  other  relevant  family  history.
is  medical  history  was  notable  for  depression  (managed
t  an  outpatient  clinic),  duodenal  peptic  ulcer  (ﬁve  years
reviously),  and  hypercholesterolemia.  His  regular  medica-
ion  consisted  of  mirtazapine  30  mg  daily,  alprazolam  0.5  mg
aily,  bupropion  300  mg  daily  and  fenoﬁbrate  200  mg  daily.
e  had  no  clinical  allergies  and  denied  smoking,  alcohol
ntake  or  any  kind  of  addiction.
Physical  examination  showed  a  well-nourished  man  with
o  external  signs  of  distress.  At  admission,  he  was  afebrile,
ith  blood  pressure  of  112/65  mmHg,  heart  rate  of
6  bpm  and  oxygen  saturation  of  98%  by  pulse  oximetry.  Car-
iac  examination  showed  an  irregular  heart  rhythm  with  no
urmurs.  The  rest  of  the  physical  examination  was  unre-
arkable.
During  his  assessment  in  the  ED,  he  suffered  a  new
pisode  of  syncope  with  spontaneous  recovery,  and  cardiac
f
p
donitoring  during  the  event  showed  a polymorphic  ven-
ricular  tachycardia  (PVT).  Despite  intravenous  infusion  of
miodarone  and  magnesium  sulphate,  there  was  recur-
ence  of  the  cardiac  arrhythmia  requiring  a total  of  ﬁve
xternal  electrical  cardioversions.  A  12-lead  electrocardio-
ram  (ECG)  recorded  during  one  such  event  is  presented  in
igure  1.
A blood  chemistry  panel  showed  normal  serum  potassium
nd  magnesium,  with  no  hypocalcemia.  Cardiac  biomark-
rs  were  negative,  and  other  laboratory  investigations
ere  unremarkable.  The  patient  was  transferred  to  our
ardiac  intensive  care  unit  for  further  assessment  and  treat-
ent.
Careful  review  of  ECG  records  (Figures  1  and  2)  showed
 short  QT  interval  (280  ms,  QTc  329  ms  according  to  the
azett  formula).  Given  the  setting  of  a  PVT  storm  coronary
ngiography  was  performed,  which  ruled  out  coronary  artery
isease  or  anomalous  coronary  origin  (Figures  3  and  4),  with
ormal  wall  motion  and  left  ventricular  ejection  fraction
70%).  Transthoracic  echocardiographic  examination  showed
 normal  heart  with  good  left  ventricular  systolic  function
nd  no  signs  of  structural  disease.
In  the  absence  of  other  causes,  a  presumptive  diagnosis  of
hort  QT  syndrome  (SQTS)  was  made,  and  quinidine  tablets
ere  requested  from  the  hospital  pharmacy.  The  patient  was
lassiﬁed  as  high-probability  SQTS  according  to  the  Gollob
riteria,1 with  a  score  of  5  (Table  1).
In-patient  24-hour  Holter  monitoring  was  performed
nd  showed  infrequent  dimorphic  premature  ventricular
ontractions  (PVCs),  with  no  repetitive  patterns.  An  elec-
rophysiologic  study  was  performed  and  was  notable  for  the
nduction  of  self-limited  PVT  with  hemodynamic  collapse
induction  protocol:  S1  400/S2  200  ms,  pacing  at  the  right
entricular  apex).  The  measured  right  ventricular  refrac-
ory  period  was  shortened  (200  ms).  No  attempt  was  made
o  induce  atrial  ﬁbrillation.  The  measured  atrial  refractory
eriod  was  350  ms  in  the  right  atrium  and  200  ms  in  the  left
trium  (as  measured  in  the  distal  coronary  sinus).
In  accordance  with  the  ACCF/AHA/HRS  guidelines  for
evice-based  therapy,2 the  patient  received  an  implantable
ardioverter-deﬁbrillator  (ICD)  as  secondary  prevention
ndicated  for  SQTS,  repeated  syncopes  and  inducible  PVT.
here  were  no  procedural  complications  and  he  was  dis-
harged  on  his  previous  medication  and  quinidine.
At  a  follow-up  visit  14  months  later,  the  patient  was
eeling  well  and  had  had  no  new  episodes  of  syncope  or
alpitations.  Physical  examination  was  unremarkable.  ICD
evice  interrogation  showed  no  shocks  or  arrhythmic  events,
Short  QT  syndrome  presenting  as  syncope  649.e3
I aVR
aVL
aVF
V1
V2
V3
V4
V5
V6
II
III
II
Equi: Veloc: 25 mm/s Membr: 10 mm/mV Tórax:   10,0 mm/mV F  50 ~ 0,15– 40 Hz PH100B        CL         P?
Figure  1  This  12-lead  ECG  recorded  during  a  syncopal  episode  shows  sinus  rhythm  with  a  heart  rate  of  83  bpm.  The  tracing  shows
a shortened  QT  interval  (320  ms)  with  frequent  premature  ventricular  contractions  (PVCs)  causing  R-on-T  extrasystoles  (red  arrow).
One PVC  (black  arrow)  triggers  polymorphic  ventricular  tachycardia  which  caused  loss  of  consciousness.
Table  1  Proposed  diagnostic  criteria  for  short  QT
syndrome.
Criterion  Points
QTc,  ms
<370  1
<350 2
<330 3
Jpoint-Tpeak  interval  <120  ms  1
Clinical history
History  of  sudden  cardiac  arrest 2
Documented  polymorphic  VT  or  VF  2
Unexplained  syncope  1
Atrial ﬁbrillation  1
Family history
First-  or  second-degree  relative  with
high-probability  SQTS
2
First-  or  second-degree  relative  with
autopsy-negative  sudden  cardiac  death
1
Sudden  infant  death  syndrome  1
Genotype
Genotype  positive  2
Mutation  of  undetermined  signiﬁcance
in a  culprit  gene
1
QTc: corrected QT; SQTS: short QT syndrome; VF: ventricular
ﬁbrillation; VT: ventricular tachycardia. High-probability SQTS: 4
points; intermediate-probability SQTS: 3 points; low-probability
SQTS: 2 points.
Adapted from Gollob et al.1
RR=0.6 8 s
QT = 2 70 ms 
Figure  2  Electrocardiographic  recording,  lead  V2,  showing
shortened  QT  interval  (270  ms)  with  RR  interval  of  0.68  s.  The
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nd  repeat  ECG  assessment  (Figure  4)  showed  a  QT  interval
f  320  ms  (QTc  347  ms).
Genetic  testing  was  performed,  and  screening  of  the
CNJ2,  KCNH2  and  KCNQ1  genes  by  polymerase  chain
eaction  was  negative  for  short  deletions  or  missense  muta-
ions.
To  the  authors’  knowledge,  this  is  the  ﬁrst  reported  case
f  STQS  in  Portugal,  which  is  in  agreement  with  the  very  low
revalence  of  this  condition.  As  an  index  case,  ECG  screening
f  family  members  is  underway.
649.e4  G.  Portugal  et  al.
Figure  3  Coronary  angiography  of  the  left  and  right  coronary  circulation  showed  no  signiﬁcant  disease.
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iscussion
udden  cardiac  death  is  one  of  the  leading  causes  of  death  in
he  industrialized  world,  and  ventricular  arrhythmias  have
ong  been  recognized  as  one  of  the  causative  mechanisms.
hile  these  usually  occur  in  the  setting  of  structural  heart
isease,  they  may  also  be  a  consequence  of  an  acute  pro-
ess  or  an  inherited  predisposition  of  an  individual’s  cardiac
issue  to  life-threatening  arrhythmias.
These  primary  cardiac  electrical  diseases,  although
ncommon,  are  usually  detected  in  younger3 and  otherwise
ealthy  individuals,  often  with  tragic  consequences.
SQTS  is  a  recently  described  entity  included  in  the  group
f  inherited  primary  electric  disorders.  As  originally  pro-
osed  by  Gussak  in  2000,4 it  involved  the  association  of  a
igniﬁcantly  shortened  QTc  interval  on  the  surface  ECG  with
trial  ﬁbrillation  and  sudden  cardiac  death.Since  its  description  in  two  families,5 our  understand-
ng  of  this  rare  entity  has  evolved,  but  there  are  still  many
uestions  to  answer,  particularly  regarding  its  incidence  and
rognosis.
o
n
eing  at  follow-up.
Our  patient  was  initially  assessed  in  the  ED  with  a  clini-
al  diagnosis  of  syncope.  While  this  is  a  common  complaint
n  the  ED,  representing  up  to  3%  of  all  visits,  its  causes
ange  from  benign  vasovagal  reactions  to  life-threatening
ardiac  arrhythmias.  In  this  clinical  setting,  the  presentation
f  recurrent  syncope  at  rest,  without  known  precipitating
vents,  suggested  a potentially  serious  underlying  process.
After  documentation  of  an  arrhythmic  cause,  the
atient’s  severe  electrical  instability  could  have  been  asso-
iated  with  an  acute  myocardial  ischemic  process,  but  this
as  ruled  out  by  persistently  negative  serum  troponin  and  a
ormal  coronary  angiogram.  In  the  absence  of  other  precip-
tating  causes,  with  ECGs  showing  a  shortened  QT  interval
ithout  structural  heart  disease,  a  presumptive  diagnosis  of
QTS  was  made.  To  our  knowledge,  this  is  the  ﬁrst  known
ocumentation  on  a  12-lead  ECG  of  R-on-T  extrasystoles  in
 short  QT-related  arrhythmic  episode.
In  contrast  with  long  QT  interval,  which  may  be  brought
n  by  external  factors,  including  certain  drugs,  there  is
o  known  association  between  medication  and  a  short-
ned  QT  interval.  However,  due  to  an  overlap  of  QTc
Short  QT  syndrome  presenting  as  syncope  649.e5
Table  2  Association  between  genotype  and  phenotype  in  short  QT  syndrome.
Type  Gene  involved  Chromosome  locus
SQTS1  KCNH2  --  potassium  voltage-gated  channel,  subfamily  H  (eag-related),  member  2  7q36.1
SQTS2 KCNQ1  --  potassium  voltage-gated  channel,  KQT-like  subfamily,  member  1  11p15.5-p15.4
SQTS3 KCNJ2  --  potassium  inwardly-rectifying  channel,  subfamily  J,  member  2  17q24.3
SQTS4 CACNA1C  --  calcium  channel,  voltage-dependent,  L  type,  alpha  1C  subunit  12p13.3
SQTS5 CACNB2  --  calcium  channel,  voltage-dependent,  beta-2  subunit  10p12.33-p12.31
SQTS6 CACNA2D1  --  calcium  channel,  voltage-dependent,  alpha-2/delta  subunit  1  7q21.11
d
p
h
p
t
t
w
i
p
A
i
f
4
n
q
w
I
p
S
w
o
b
I
p
G
t
a
c
y
h
w
s
p
t
i
h
w
b
o
t
t
Document downloaded from http://www.elsevier.pt, day 30/12/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.Adapted from Comelli et al.13
values  between  healthy  population  cohorts  and  patients
with  SQTS,6,7 hyperkalemia,  hypo-  or  hypercalcemia,  sinus
tachycardia,  hypothermia,  acidosis  or  digoxin  therapy  must
be  excluded.  A  case  of  short  QT  related  to  prolonged  resus-
citation  efforts  and  hypothermia  has  also  been  described,8
but  this  was  not  the  case  in  our  patient.
Similarly  to  the  long  QT  syndrome,  there  appears  to  be
signiﬁcant  overlap  of  QTc  values  between  healthy  popula-
tion  cohorts  and  patients  with  SQTS.6,7 This  suggests  that
an  abbreviated  QT  interval  is  not  in  itself  the  cause  of  an
increased  risk  of  arrhythmia,  but  may  be  a  surface  surro-
gate  for  the  arrhythmogenic  substrate  in  SQTS  patients.  As
such,  a  diagnosis  of  short  QT  syndrome  should  only  be  con-
sidered  following  careful  assessment  of  the  12-lead  ECG,  in
an  appropriate  clinical  setting  (history  of  syncope  or  aborted
sudden  cardiac  death,  positive  family  history),  as  suggested
by  the  Gollob  score.
As  the  QT  interval  is  heart-rate  dependent,  use  of  the
Bazett  formula  allows  estimation  of  the  real  QT  interval  (as
measured  at  60  bpm)  at  any  heart  rate.  Some  caution  must
be  used  in  its  application,  as  the  formula  has  been  reported
to  undercorrect  (yielding  erroneously  high  QTc  intervals)  at
heart  rates  above  90  bpm.14 However,  measuring  the  QT
interval  at  a  heart  rate  of  60  bpm  is  not  always  feasible  in
clinical  practice  as  it  may  require  the  use  of  beta-blockers
or  Holter  monitoring,  and  the  Bazett  formula  remains  an
acceptably  simple  and  effective  tool  at  the  bedside.
The  described  cellular  mechanism  behind  idiopathic
short  QT  interval  is  usually  related  to  gain-of-function  muta-
tions  in  potassium  channels;  these  lead  to  a  shortened
action  potential  duration  through  accelerated  cardiomy-
ocyte  repolarization.  So  far,  six  different  genotypes  have
been  conclusively  associated  with  SQTS  (Table  2),  but
genetic  testing  was  negative  in  71%  of  the  reported  cases,1
suggesting  that  other  genetic  mutations  remain  to  be  iden-
tiﬁed.
Although  genetic  testing  has  so  far  shown  a  low  diagnostic
yield,  a  hereditary  component  was  found  in  71.9%  of  index
cases  in  the  study  by  Gollob  et  al.2 However,  application  of
a  diagnostic  score  to  family  members  may  underestimate
the  prevalence  of  SQTS  due  to  the  incomplete  penetrance
of  inherited  cardiac  electrical  disorders.  ECG  screening  of
family  members  appears  to  be  a  practical  and  cost-effective
tool.The  ideal  long-term  management  of  this  rare  clinical
entity  has  yet  to  be  established.  In  theory,  pharmacological
therapy  with  a  QT-prolonging  drug  should  be  effective  in  cor-
recting  the  short  QT  interval;  however,  most  QT-prolonging
f
n
p
trugs,  such  as  ﬂecainide  or  sotalol,  are  ineffective  in  these
atients.9 Recent  data  show  that  most  QT-prolonging  drugs
ave  the  highest  afﬁnity  for  the  inactivated  state  of  the
otassium  channel  Kv11.1.10 Curiously,  in  SQTS,  Kv11.1  inac-
ivation  is  usually  abolished,  conferring  relative  resistance
o  the  action  of  these  drugs.  An  exception  is  quinidine,
hich  binds  with  equal  afﬁnity  to  both  the  activated  and
nactivated  states  of  Kv11.1,  and  has  proved  effective  in
rolonging  the  QT  interval  up  to  normal  in  these  patients.9,7
 recent  report  has  shown  that  the  arrhythmic  event  rate
n  SQTS  patients  taking  hydroquinidine  during  long-term
ollow-up  was  lower  than  if  no  drug  was  used  (0.0%  vs.
.9%/year),  although  this  difference  was  not  statistically  sig-
iﬁcant,  probably  owing  to  the  small  sample  size.11 Thus,
uinidine  may  be  a  useful  treatment  for  selected  patients
ith  SQTS,  such  as  those  with  contraindication  to  or  refusing
CD  implantation.
Current  guidelines2 recommend  ICD  implantation  for
atients  with  genetic  arrhythmia  syndromes  (including
QTS)  and  prior  cardiac  arrest  or  syncope,  and  also  for  those
ith  a  family  history  of  sudden  cardiac  death  and  induction
f  ventricular  tachyarrhythmias,  as  they  are  considered  to
e  at  high  risk  for  recurrent  malignant  arrhythmic  events.
mplantation  for  primary  prevention  may  be  considered  in
atients  classiﬁed  as  high  probability  on  the  basis  of  their
ollob  score.1
In  our  patient,  no  arrhythmic  events  or  relevant  symp-
oms  were  recorded  during  a  14-month  follow-up.  This  is  in
greement  with  the  reported  low  incidence  of  events  in  a
ohort  of  SQTS  patients,13 with  an  event  rate  of  3.3%  per
ear.  Speciﬁcally,  in  the  subset  of  patients  presenting  with  a
istory  of  syncope,  only  one  event  was  observed,  in  a  patient
ith  a  hERG  mutation  (SQTS1)  who  received  an  appropriate
hock  for  ventricular  ﬁbrillation.
Among  the  causes  of  sudden  cardiac  death  in  young
eople,  SQTS  is  a  relatively  recent  entity.  The  recogni-
ion  of  this  rare  syndrome  has  allowed  reclassiﬁcation  of
ndividuals  who  would  previously  have  been  classiﬁed  as
aving  idiopathic  ventricular  ﬁbrillation,  as  is  the  case
ith  our  patient.  Any  suspected  cases  of  SQTS  should
e  referred  to  specialized  centers  where  they  can  be
ffered  a  multidisciplinary  approach  and  disease-speciﬁc
herapeutic  interventions,  such  as  quinidine  or  ICD  implan-
ation,  according  to  SQTS  risk  stratiﬁcation.  In  the  future,
urther  advances  in  our  knowledge  of  inherited  chan-
elopathies  will  hopefully  help  in  the  early  recognition  and
revention  of  arrhythmic  events  in  this  high-risk  popula-
ion.
6E
P
d
w
c
M
C
f
t
R
o
s
i
C
T
R
1
1
1
1
Document downloaded from http://www.elsevier.pt, day 30/12/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.49.e6  
thical disclosures
rotection  of  human  and  animal  subjects.  The  authors
eclare  that  the  procedures  followed  were  in  accordance
ith  the  regulations  of  the  relevant  clinical  research  ethics
ommittee  and  with  those  of  the  Code  of  Ethics  of  the  World
edical  Association  (Declaration  of  Helsinki).
onﬁdentiality  of  data.  The  authors  declare  that  they  have
ollowed  the  protocols  of  their  work  center  on  the  publica-
ion  of  patient  data.
ight  to  privacy  and  informed  consent.  The  authors  have
btained  the  written  informed  consent  of  the  patients  or
ubjects  mentioned  in  the  article.  The  corresponding  author
s  in  possession  of  this  document.
onﬂicts of interest
he  authors  have  no  conﬂicts  of  interest  to  declare.
eferences
1. Gollob M, Redpath C, Roberts J. The short QT syndrome -- pro-
posed diagnostic criteria. JACC. 2011;57:802--12.
2. Tracy CM, Epstein AE, Darbar D, et al. American College
of Cardiology Foundation/American Heart Association Task
Force on Practice Guidelines and the Heart Rhythm Society
2012. ACCF/AHA/HRS Focused Update incorporated into the
ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of
Cardiac Rhythm Abnormalities. JACC. 2013;61:e6--75.
1G.  Portugal  et  al.
3. Liberthson RR. Sudden death from cardiac causes in children
and young adults. N Engl J Med. 1996;334:1039--44.
4. Gussak I, Brugada P, Brugada J, et al. Idiopathic short QT inter-
val: a new clinical syndrome? Cardiology. 2000;94:99--102.
5. Gaita F, Giustetto C, Bianchi F, et al. Short QT syndrome:
a familial cause of sudden death. Circulation. 2003;108:
965--70.
6. Anttonen O, Junttila MJ, Rissanen H, et al. Prevalence and pro-
gnostic signiﬁcance of short QT interval in a middle-aged Finnish
population. Circulation. 2007;116:714--20.
7. Gallagher MM, Magliano G, Yap YG, et al. Distribution and
prognostic signiﬁcance of QT intervals in the lowest half
centile in 12,012 apparently healthy persons. Am J Cardiol.
2006;98:933--5.
8. Okishige K, Sugiyama K, Maeda M, et al. Aborted sudden car-
diac death associated with short QT syndrome. J Arrhythmia.
2009;25:214--8.
9. Gaita F, Giustetto C, Bianchi F, et al. Short QT syndrome: phar-
macological treatment. J Am Coll Cardiol. 2004;43:1494--9.
0. Perrin MJ, Kuchel PW, Campbell TJ, et al. Drug binding to
the inactivated state is necessary but not sufﬁcient for high-
afﬁnity binding to human ether-à-go-go-related gene channels.
Mol Pharmacol. 2008;74:1443--52.
1. Giustetto C, Schimpf R, Mazzanti A, et al. Long-term follow-
up of patients with short QT syndrome. J Am Coll Cardiol.
2011;58:587--95.
2. Bazett HC. An analysis of the time-relations of electrocardio-
grams. Heart. 1920;7:353--70.
3. Comelli I, Lippi G, Mossini G, et al. The dark side of the QT
interval. The short QT syndrome: pathophysiology, clinical pre-
sentation and management. Emerg Care J. 2012;3:41--7.
4. Wernicke JF, Faries D, Breitung R, et al. QT correction meth-
ods in children and adolescents. Cardiovasc Electrophysiol.
2005;16:76--81.
